Simulations Plus Revenue 2010-2024 | SLP
Simulations Plus revenue from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Simulations Plus Annual Revenue
(Millions of US $) |
| 2024 |
$70 |
| 2023 |
$60 |
| 2022 |
$54 |
| 2021 |
$46 |
| 2020 |
$42 |
| 2019 |
$34 |
| 2018 |
$30 |
| 2017 |
$24 |
| 2016 |
$20 |
| 2015 |
$18 |
| 2014 |
$11 |
| 2013 |
$10 |
| 2012 |
$9 |
| 2011 |
$9 |
| 2010 |
$11 |
| 2009 |
$9 |
Simulations Plus Quarterly Revenue
(Millions of US $) |
| 2024-08-31 |
$19 |
| 2024-05-31 |
$19 |
| 2024-02-29 |
$18 |
| 2023-11-30 |
$15 |
| 2023-08-31 |
$16 |
| 2023-05-31 |
$16 |
| 2023-02-28 |
$16 |
| 2022-11-30 |
$12 |
| 2022-08-31 |
$12 |
| 2022-05-31 |
$15 |
| 2022-02-28 |
$15 |
| 2021-11-30 |
$12 |
| 2021-08-31 |
$10 |
| 2021-05-31 |
$13 |
| 2021-02-28 |
$13 |
| 2020-11-30 |
$11 |
| 2020-08-31 |
$10 |
| 2020-05-31 |
$12 |
| 2020-02-29 |
$10 |
| 2019-11-30 |
$9 |
| 2019-08-31 |
$8 |
| 2019-05-31 |
$10 |
| 2019-02-28 |
$8 |
| 2018-11-30 |
$8 |
| 2018-08-31 |
$7 |
| 2018-05-31 |
$9 |
| 2018-02-28 |
$7 |
| 2017-11-30 |
$7 |
| 2017-08-31 |
$6 |
| 2017-05-31 |
$7 |
| 2017-02-28 |
$6 |
| 2016-11-30 |
$5 |
| 2016-08-31 |
$4 |
| 2016-05-31 |
$6 |
| 2016-02-29 |
$5 |
| 2015-11-30 |
$5 |
| 2015-08-31 |
$4 |
| 2015-05-31 |
$6 |
| 2015-02-28 |
$5 |
| 2014-11-30 |
$4 |
| 2014-08-31 |
$2 |
| 2014-05-31 |
$4 |
| 2014-02-28 |
$3 |
| 2013-11-30 |
$3 |
| 2013-08-31 |
$2 |
| 2013-05-31 |
$3 |
| 2013-02-28 |
$3 |
| 2012-11-30 |
$2 |
| 2012-08-31 |
$2 |
| 2012-05-31 |
$3 |
| 2012-02-29 |
$3 |
| 2011-11-30 |
$2 |
| 2011-08-31 |
$2 |
| 2011-05-31 |
$3 |
| 2011-02-28 |
$3 |
| 2010-11-30 |
$2 |
| 2010-08-31 |
$2 |
| 2010-05-31 |
$3 |
| 2010-02-28 |
$3 |
| 2009-11-30 |
$2 |
| 2009-08-31 |
$2 |
| 2009-05-31 |
$3 |
| 2009-02-28 |
$2 |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Computer Software |
$0.621B |
$0.070B |
|
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab, which are based on its proprietary software technologies.
|
